Changmao Biochemical Engineering Company Limited provided earnings guidance for the six months ended 30 June 2020. For the period, the company expects to record a consolidated net profit attributable to the equity holders of the Company for the six months ended 30 June 2020 of approximately RMB 12,000,000 to RMB 18,000,000, which represents a significant decline as compared to that of approximately RMB 42,528,000 for the 6 months ended 30 June 2019.